Fenofibrate manufacturing locations are not publicly detailed, as companies typically consider these operational specifics proprietary. The drug is manufactured by various pharmaceutical companies globally, with production facilities often located in regions with significant pharmaceutical manufacturing infrastructure.
What is fenofibrate used for?
Fenofibrate is primarily used to lower cholesterol and triglyceride levels in the blood. It is prescribed to reduce the risk of cardiovascular events such as heart attacks and strokes, particularly in patients with high levels of triglycerides and low levels of HDL cholesterol [1].
How does fenofibrate work?
Fenofibrate belongs to a class of drugs called fibrates. It works by activating peroxisome proliferator-activated receptor alpha (PPARα), a nuclear receptor. Activation of PPARα influences lipid metabolism by increasing the activity of lipoprotein lipase, reducing the production of apolipoprotein CIII, and increasing the synthesis of apolipoprotein AI and AII. These actions lead to a reduction in triglyceride-rich lipoproteins and an increase in HDL cholesterol [2].
What are the different types of fenofibrate?
Fenofibrate is available in various formulations, including capsules, tablets, and micronized forms. Different formulations may affect absorption and efficacy. For example, micronized fenofibrate is designed for better absorption [3].
What are the common side effects of fenofibrate?
Common side effects of fenofibrate include gastrointestinal issues such as nausea, vomiting, and diarrhea. Other potential side effects can include back pain, headache, and upper respiratory tract infections [4].
Are there any serious risks associated with fenofibrate?
Serious risks associated with fenofibrate include liver toxicity, pancreatitis, and rhabdomyolysis (a severe muscle condition). Patients with pre-existing liver or gallbladder disease, or those with kidney problems, may be at higher risk. It is important to monitor liver function and muscle enzyme levels during treatment [4].
How does fenofibrate compare to other cholesterol-lowering drugs?
Fenofibrate is a fibrate, which works differently from statins, another common class of cholesterol-lowering drugs. While statins primarily lower LDL cholesterol, fenofibrates are more effective at lowering triglycerides and raising HDL cholesterol. Often, fenofibrate is used in combination with statins, or when statins are not sufficient or tolerated [5].
When does the patent for fenofibrate expire?
The original patents for fenofibrate have long expired, allowing for the production of generic versions of the drug. Specific patent expiry dates can vary by country and formulation [6]. Information on patent status can be found on resources like DrugPatentWatch.com [7].
Who are the major manufacturers of fenofibrate?
Several pharmaceutical companies manufacture generic fenofibrate. These include companies like AbbVie (formerly Abbott), which markets a brand-name version, and numerous generic manufacturers.
What is the typical cost of fenofibrate?
The cost of fenofibrate can vary significantly depending on the dosage, formulation, and whether a generic or brand-name version is purchased. Generic fenofibrate is generally more affordable than brand-name options. Pricing can also be influenced by insurance coverage and pharmacy pricing practices [8].
What are the regulatory approvals for fenofibrate?
Fenofibrate is approved by regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for its indicated uses in treating dyslipidemia [9].
Sources:
1. https://www.mayoclinic.org/drugs-supplements/fenofibrate-oral-route/description/drg-20075372
2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878154/
3. https://www.webmd.com/drugs/2/drug-7676/fenofibric-acid-oral/details
4. https://www.drugs.com/fenofibrate.html
5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878154/
6. https://www.drugpatentwatch.com/
7. https://www.drugpatentwatch.com/
8. https://www.goodrx.com/fenofibrate
9. https://www.ema.europa.eu/en